Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patients.

Diabetes & vascular disease research - 1 Jan 2012

Bleda Silvia, De Haro Joaquin, Varela Cesar, Esparza Leticia, Ferruelo Antonio, Acin Francisco

Abstract excerpt

AIM: To determine the potential genotype differences in the vascular endothelial growth factor (VEGF) gene in diabetic patients, which might explain the difference in terms of the development of clinical vascular complications: great vessels atherosclerosis vs. retinopathy. METHODS: Genotyping of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross-Sectional Studies
Share to Diabetes Mellitus, Type 2
Share to Diabetic Retinopathy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Logistic Models

Share to Mutagenesis, Insertional

Share to Peripheral Arterial Disease

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 22064697
DOI: 10.1177/1479164111426162

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22064697-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patients.PMID 22064697Read ↗

Impact of VEGF polymorphisms on the severity of peripheral artery disease in diabetic patients.Semantic proximity Read ↗

Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes.Semantic proximity Read ↗

Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients.Semantic proximity Read ↗

Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients.Semantic proximity Read ↗

Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy.Semantic proximity Read ↗

Association between the vascular endothelial growth factor single nucleotide polymorphisms and diabetic retinopathy risk: A meta-analysis.Semantic proximity Read ↗

A Study of VEGF Gene Polymorphism in Egyptian Patients with Diabetic Retinopathy.Semantic proximity Read ↗

Association of vascular endothelial growth factor A gene (VEGFA) polymorphisms, rs699947 and rs1570360, with diabetic retinopathy and altered VEGF secretion in Pakistani patients with Type 2 diabetes mellitus: A case-control studySemantic proximity Read ↗

Association of VEGF Gene Polymorphisms with Susceptibility to Diabetic Retinopathy: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?Semantic proximity Read ↗

Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy.Semantic proximity Read ↗

Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.